The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure: A Randomized, Controlled Trial
Abstract
BACKGROUND: Albumin dialysis with the Molecular Adsorbent Recirculating System (MARS) (Gambro, Lund, Sweden), a noncell artificial liver support device, may be beneficial in acute liver failure (ALF). OBJECTIVE: To determine whether MARS improves survival in ALF. DESIGN: Randomized, controlled trial. (ClinicalTrials.gov: NCT00224705). SETTING: 16 French liver transplantation centers. PATIENTS: 102 patients with ALF. INTERVENTION: Conventional treatment (n = 49) or MARS with conventional treatment (n = 53), stratified according to whether paracetamol caused ALF. MEASUREMENTS: 6-month survival and secondary end points, including adverse events. RESULTS: 102 patients (mean age, 40.4 years [SD, 13]) were in the modified intention-to-treat (mITT) population. The per-protocol analysis (49 conventional, 39 MARS) included patients with at least 1 session of MARS of 5 hours or more. Six-month survival was 75.5% (95% CI, 60.8% to 86.2%) with conventional treatment and 84.9% (CI, 71.9% to 92.8%) with MARS (P = 0.28) in the mITT population and 75.5% (CI, 60.8% to 86.2%) with conventional treatment and 82.9% (CI, 65.9% to 91.9%) with MARS (P = 0.50) in the per-protocol population. In patients with paracetamol-related ALF, the 6-month survival rate was 68.4% (CI, 43.5% to 86.4%) with conventional treatment and 85.0% (CI, 61.1% to 96.0%) with MARS (P = 0.46) in the mITT population. Sixty-six of 102 patients had transplantation (41.0% among paracetamol-induced ALF; 79.4% among non-paracetamol-induced ALF) (P < 0.001). Adverse events did not significantly differ between groups. LIMITATION: The short delay from randomization to liver transplantation (median, 16.2 hours) precludes definitive efficacy or safety evaluations. CONCLUSION: This randomized trial of MARS in patients with ALF was unable to provide definitive efficacy or safety conclusions because many patients had transplantation before administration of the intervention. Acute liver failure not caused by paracetamol was associated with greater 6-month patient survival. PRIMARY FUNDING SOURCE: Assistance Publique-Hôpitaux de Paris.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
Acute liver failure: redefining the syndromes
Williams, R., Schalm, S. W., & O'Grady, J. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91818-7 · Cited by 966
Demetriou, A. A., Brown, R. S., Busuttil, R. W., Fair, J., McGuire, B. M., Rosenthal, P., Am Esch, J. S., Lerut, J., Nyberg, S. L., Salizzoni, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000124298.74199.e5 · Cited by 677
Fulminant and Subfulminant Liver Failure: Definitions and Causes
Bernuau, J., Rueff, B., & Benhamou, J.-P. (1986) · Seminars in Liver Disease · doi:10.1055/s-2008-1040593 · Cited by 632
Bernal, W., Donaldson, N., Wyncoll, D., & Wendon, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07743-7 · Cited by 511
Multivariate analysis of prognostic factors in fulminant hepatitis B
Bernuau, J., Goudeau, A., Poynard, T., Dubois, F., Lesage, G., Yvonnet, B., Degott, C., Bezeaud, A., Rueff, B., & Benhamou, J.-P. (1986) · Hepatology · doi:10.1002/hep.1840060417 · Cited by 501
Classification of acute liver failure
O'Grady, J., & Williams, R. (1993) · The Lancet · doi:10.1016/0140-6736(93)91736-6 · Cited by 349
Emergency Liver Transplantation for Fulminant Hepatitis
BISMUTH, H., SAMUEL, D., GUGENHEIM, J., CASTAING, D., BERNUAU, J., RUEFF, B., & BENHAMOU, J.-P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-337 · Cited by 283
Self-citationSchmidt, L. E., Wang, L. P., Hansen, B. A., & Larsen, F. S. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50051 · Cited by 231
Cited by
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Self-citationACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Larsen, F. S., Schmidt, L. E., Bernsmeier, C., Rasmussen, A., Isoniemi, H., Patel, V. C., Triantafyllou, E., Bernal, W., Auzinger, G., Shawcross, D., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.018 · Cited by 659
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Metadata
- Authors
- Saliba, F., Camus, C., Durand, F., Mathurin, P., Letierce, A., Delafosse, B., Barange, K., Perrigault, P. F., Belnard, M., Ichaï, P., & Samuel, D.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2013-10-15
- Volume
- 159
- Issue
- 8
- Pages
- 522-531
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1964555364
- Cited by
- 292
- References
- 18
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure: A Randomized, Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-159-8-201310150-00005
- The paper
- Saliba, F., Camus, C., Durand, F., Mathurin, P., Letierce, A., Delafosse, B., Barange, K., Perrigault, P. F., Belnard, M., Ichaï, P., & Samuel, D. (2013). Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure: A Randomized, Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-159-8-201310150-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.